Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypertension

  Free Subscription


11.03.2019

1 Cardiol Clin
2 Diabetes Care
2 Hypertension
2 J Cardiovasc Pharmacol
1 J Hum Hypertens
1 J Hypertens
2 J Neurosurg
1 JAMA
1 Kidney Int
1 Lancet Oncol
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cardiol Clin

  1. IWAI S
    Sudden Cardiac Death Risk Stratification and the Role of the Implantable Cardiac Defibrillator.
    Cardiol Clin. 2019;37:63-72.
    PubMed     Text format     Abstract available


    Diabetes Care

  2. CHEUNG NW, Moses RG
    Response to Comment on Cheung and Moses. Gestational Diabetes Mellitus: Is It Time to Reconsider the Diagnostic Criteria? Diabetes Care 2018;41:1337-1338.
    Diabetes Care. 2019;42:e13.
    PubMed     Text format    

  3. SACKS DA
    Comment on Cheung and Moses. Gestational Diabetes Mellitus: Is It Time to Reconsider the Diagnostic Criteria? Diabetes Care 2018;41:1337-1338.
    Diabetes Care. 2019;42:e11-e12.
    PubMed     Text format    


    Hypertension


  4. Correction to: IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure.
    Hypertension. 2019;73:e12.
    PubMed     Text format    

  5. VERDECCHIA P, Angeli F, Cavallini C, Aita A, et al
    Sudden Cardiac Death in Hypertensive Patients.
    Hypertension. 2019 Mar 4:HYPERTENSIONAHA11912684.
    PubMed     Text format     Abstract available


    J Cardiovasc Pharmacol

  6. SALAH E, Bastacky SI, Jackson EK, Tofovic SP, et al
    2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
    J Cardiovasc Pharmacol. 2019;73:165-177.
    PubMed     Text format     Abstract available

  7. HAMANO G, Yamamoto K, Takami Y, Takeshita H, et al
    Effects of low-dose sacubitril/valsartan on different stages of cardiac hypertrophy in salt-loaded hypertensive rats.
    J Cardiovasc Pharmacol. 2019 Feb 28. doi: 10.1097/FJC.0000000000000662.
    PubMed     Text format     Abstract available


    J Hum Hypertens

  8. FACONTI L, Ferro A, Webb AJ, Cruickshank JK, et al
    Hydrochlorothiazide and the risk of skin cancer. A scientific statement of the British and Irish Hypertension Society.
    J Hum Hypertens. 2019 Mar 6. pii: 10.1038/s41371-019-0190.
    PubMed     Text format    


    J Hypertens

  9. CHAPPELL MC
    Hydrogen sulfide, then nitric oxide and vasoprotection.
    J Hypertens. 2018;36:493-494.
    PubMed     Text format    


    J Neurosurg

  10. ROBBA C, Donnelly J, Cardim D, Tajsic T, et al
    Optic nerve sheath diameter ultrasonography at admission as a predictor of intracranial hypertension in traumatic brain injured patients: a prospective observational study.
    J Neurosurg. 2019 Mar 8:1-7. doi: 10.3171/2018.11.JNS182077.
    PubMed     Text format     Abstract available

  11. YAN F, Rajah G, Ding Y, Hua Y, et al
    Safety and efficacy of intravascular ultrasound as an adjunct to stenting for cerebral venous sinus stenosis-induced idiopathic intracranial hypertension: a pilot study.
    J Neurosurg. 2019 Mar 1:1-6. doi: 10.3171/2018.11.JNS181885.
    PubMed     Text format     Abstract available


    JAMA

  12. WILLIAMSON JD, Pajewski NM, Auchus AP, Bryan RN, et al
    Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
    JAMA. 2019;321:553-561.
    PubMed     Text format     Abstract available


    Kidney Int

  13. VAN ROEYEN CRC, Martin IV, Drescher A, Schuett KA, et al
    Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.
    Kidney Int. 2019 Feb 28. pii: S0085-2538(18)30920.
    PubMed     Text format     Abstract available


    Lancet Oncol

  14. CHOUEIRI TK, Larkin J, Oya M, Thistlethwaite F, et al
    Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.
    Lancet Oncol. 2018;19:451-460.
    PubMed     Text format     Abstract available


    PLoS One

  15. RYU Y, Kee HJ, Sun S, Seok YM, et al
    Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.
    PLoS One. 2019;14:e0213186.
    PubMed     Text format     Abstract available

  16. SU W, Li Z, Jia Y, Zhuo Y, et al
    Correction: Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model.
    PLoS One. 2019;14:e0213489.
    PubMed     Text format     Abstract available

  17. OKUYAMA K, Akai K, Kijima T, Abe T, et al
    Effect of geographic accessibility to primary care on treatment status of hypertension.
    PLoS One. 2019;14:e0213098.
    PubMed     Text format     Abstract available

  18. HUNTER MD, Park Moon Y, DeCarli C, Gutierrez J, et al
    Electrocardiographic left atrial abnormality and silent vascular brain injury: The Northern Manhattan Study.
    PLoS One. 2018;13:e0203774.
    PubMed     Text format     Abstract available

  19. CHEN Q, Hartman CA, Haavik J, Harro J, et al
    Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
    PLoS One. 2018;13:e0204516.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: